Relaxo Footwears Limited (RELAXO) Fair Value & Analysis
Consumer Cyclical · IN · Market cap ₹101B
Fair value as of: Jul 3, 2026
From 26 valuation models · updated today
Share price +17.6% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹237.90 – ₹515.58 · fair‑value band ₹109.19 – ₹187.56 · the ₹397.15 price screens above the ₹148.37 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Relaxo Footwears Limited (RELAXO) currently trades at ₹397.15, while our model-based Fair Value estimate is ₹148.37 — implying the stock looks roughly 62.6% overvalued today. We read business quality at 58/100 (solid quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Relaxo Footwears Limited generated revenue of ₹27.0B at a net margin of 6.6%. Revenue grew 8.0% year over year. It earns a return on equity of 8.3%. Net debt stands at ₹2.1B. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Relaxo Footwears Limited engages in the manufacture and sale of footwear for men, women, and kids in India and internationally. It offers casual, running, athleisure, walking, sneakers, formal, sports, school, and training and gym shoes; and slippers, sandals, flip flops, slides, chappals, and clogs, as well as footwear accessories. The company provides its products under the Relaxo, Bahamas, Flite, Sparx, BOSTON, Mary Jane, Schoolmate, and KidsFun brands. It sells its products through exclusive brand outlets and e-commerce portals. Relaxo Footwears Limited was founded in 1976 and is based in New Delhi, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Relaxo Footwears Limited reported revenue of ₹27.0B in FY2026 versus ₹26.5B in FY2022, a compound +0.5%/yr. Reported net income was ₹1.8B in FY2026, compounding −6.3%/yr from FY2022.
Is RELAXO fairly valued? → Check now
Similar stocks
6 more Footwear & Accessories stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| NIKE, Inc NKE | €38.07 | €45.62 | +20% |
| adidas AG 1ADS | €184.40 | €81.86 | -56% |
| ASICS Corporation ASCCY | $27.42 | $22.91 | -16% |
| Deckers Outdoor Corporation DECK | $111.18 | $125.16 | +13% |
| On Holding ONON | $38.00 | $18.63 | -51% |
| Zhejiang China Commodities City Group 600415 | ¥11.37 | ¥23.62 | +108% |
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is Relaxo Footwears Limited (RELAXO) undervalued?
What is the fair value of RELAXO?
What is the quality score of RELAXO?
What is the revenue of Relaxo Footwears Limited (RELAXO)?
What is the net profit margin of RELAXO?
Does Relaxo Footwears Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.